Laboratory Co. of America - LH Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
News Sentiment
About
FAQ

Consensus Rating: Buy
Consensus Price Target: $273.50
Forecasted Upside: 26.05%
Number of Analysts: 9
Breakdown:
0 Sell Ratings
2 Hold Ratings
7 Buy Ratings
0 Strong Buy Ratings

^$216.98 As of 06/2/2023 05:32 PM ET

▲ +4.54 (2.14%)

1 month | 3 months | 12 months

Get New Laboratory Co. of America Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for LH and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for LH

^$273.50

▲ +26.05% Upside Potential

This price target is based on 9 analysts offering 12 month price targets for Laboratory Co. of America in the last 3 months. The average price target is $273.50, with a high forecast of $303.00 and a low forecast of $235.00. The average price target represents a 26.05% upside from the last price of $216.98.

Current Consensus is Buy

The current consensus among 9 polled investment analysts is to buy stock in Laboratory Co. of America. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
7 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

12/9/2021

0 strong buy ratings
7 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

3/9/2022

0 strong buy ratings
6 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

6/7/2022

0 strong buy ratings
5 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

9/5/2022

0 strong buy ratings
7 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

12/4/2022

0 strong buy ratings
7 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

3/4/2023

0 strong buy ratings
7 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

5/3/2023

0 strong buy ratings
7 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

6/2/2023

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
5/16/2023	Mizuho	Lower Target		$277.00 ➝ $257.00	Low
5/1/2023	Truist Financial	Lower Target		$285.00 ➝ $275.00	Low
4/26/2023	Deutsche Bank Aktiengesellschaft	Lower Target		$265.00 ➝ $240.00	Low
4/26/2023	Citigroup	Lower Target		$260.00 ➝ $235.00	Low
3/13/2023	Credit Suisse Group	Lower Target	Outperform	$304.00 ➝ $288.00	Low
2/21/2023	Credit Suisse Group	Lower Target	Outperform	$305.00 ➝ $304.00	Low
2/21/2023	Wells Fargo & Company	Lower Target	Overweight	$315.00 ➝ $290.00	Low
2/17/2023	Truist Financial	Boost Target	Buy	$275.00 ➝ $285.00	Low
2/17/2023	Citigroup	Boost Target	Neutral	$250.00 ➝ $260.00	Low
2/17/2023	Robert W. Baird	Boost Target	Outperform	$300.00	Low
2/17/2023	Mizuho	Boost Target	Buy	$250.00 ➝ $277.00	Low
1/11/2023	Robert W. Baird	Boost Target	Outperform	$270.00 ➝ $285.00	Low
1/6/2023	Morgan Stanley	Boost Target	Overweight	$290.00 ➝ $303.00	Low
12/12/2022	Citigroup	Downgrade	Buy ➝ Neutral	$275.00 ➝ $250.00	Low
11/23/2022	Credit Suisse Group	Lower Target	Outperform	$308.00 ➝ $305.00	Low
11/3/2022	Mizuho	Lower Target	Buy	$296.00 ➝ $250.00	Low
10/31/2022	Morgan Stanley	Lower Target	Overweight	$300.00 ➝ $290.00	Low
10/28/2022	Truist Financial	Lower Target	Buy	$275.00 ➝ $260.00	Low
10/28/2022	Citigroup	Lower Target		$300.00 ➝ $275.00	Low
10/28/2022	Robert W. Baird	Lower Target		$297.00 ➝ $270.00	Low
10/27/2022	William Blair	Reiterated Rating	Outperform		Low
9/19/2022	Argus	Downgrade	Buy ➝ Hold		Low
8/22/2022	Morgan Stanley	Reiterated Rating	Overweight	$300.00	Low
8/9/2022	Credit Suisse Group	Lower Target		$308.00	Low
8/4/2022	Robert W. Baird	Boost Target	Outperform	$295.00 ➝ $297.00	Low
8/1/2022	Credit Suisse Group	Lower Target	Outperform	$312.00 ➝ $308.00	Low
5/25/2022	Morgan Stanley	Lower Target	Overweight	$360.00 ➝ $300.00	Low
5/4/2022	Mizuho	Lower Target		$354.00 ➝ $323.00	Low
5/3/2022	Deutsche Bank Aktiengesellschaft	Lower Target		$294.00 ➝ $265.00	Low
5/2/2022	Credit Suisse Group	Lower Target		$344.00 ➝ $312.00	Medium
4/29/2022	Truist Financial	Lower Target		$350.00 ➝ $320.00	Low
4/25/2022	Wells Fargo & Company	Lower Target	Equal Weight	$290.00 ➝ $235.00	Medium
2/14/2022	Morgan Stanley	Lower Target	Overweight	$380.00 ➝ $360.00	Low
2/11/2022	Wells Fargo & Company	Lower Target		$340.00 ➝ $320.00	High
2/11/2022	Credit Suisse Group	Boost Target	Outperform	$340.00 ➝ $344.00	High
2/11/2022	Citigroup	Boost Target		$340.00 ➝ $350.00	High
1/28/2022	Deutsche Bank Aktiengesellschaft	Downgrade	Buy ➝ Hold	$330.00 ➝ $294.00	High
12/20/2021	Mizuho	Boost Target	Buy	$332.00 ➝ $354.00	Low
12/17/2021	Morgan Stanley	Boost Target	Overweight	$377.00 ➝ $380.00	Low
12/14/2021	Wells Fargo & Company	Boost Target	Overweight ➝ Overweight	$330.00 ➝ $340.00	Medium
11/1/2021	Credit Suisse Group	Boost Target	Outperform	$336.00 ➝ $338.00	Low
10/29/2021	Morgan Stanley	Boost Target	Overweight	$368.00 ➝ $377.00	Low
8/31/2021	Morgan Stanley	Boost Target	Overweight	$273.00 ➝ $368.00	Low
8/20/2021	Credit Suisse Group	Boost Target	Outperform	$295.00 ➝ $336.00	Low
8/19/2021	Mizuho	Boost Target	Buy	$318.00 ➝ $332.00	Medium
7/30/2021	Truist Financial	Boost Target	Positive ➝ Buy	$330.00 ➝ $350.00	Low
7/30/2021	Deutsche Bank Aktiengesellschaft	Boost Target	Buy	$297.00 ➝ $330.00	Medium
7/30/2021	Mizuho	Boost Target	Buy	$310.00 ➝ $318.00	Medium
7/21/2021	Robert W. Baird	Set Target	Buy	$276.78	Low
5/20/2021	Argus	Boost Target	Average ➝ Buy	$270.00 ➝ $295.00	Medium
5/12/2021	Mizuho	Boost Target	Buy	$267.00 ➝ $310.00	Low
5/3/2021	Truist Financial	Boost Target		$300.00 ➝ $320.00	Low
5/3/2021	Citigroup	Boost Target		$278.00 ➝ $312.00	Low
5/3/2021	Jefferies Financial Group	Boost Target	Buy	$300.00 ➝ $310.00	Low
4/14/2021	Truist Financial	Boost Target	Above Average ➝ Buy	$280.00 ➝ $300.00	Medium
4/1/2021	Jefferies Financial Group	Reiterated Rating	Buy		High
2/12/2021	Citigroup	Boost Target	Buy	$257.00 ➝ $278.00	Low
2/12/2021	JPMorgan Chase & Co.	Boost Target	Overweight	$261.00 ➝ $279.00	Low
2/12/2021	Mizuho	Boost Target	Buy	$242.00 ➝ $267.00	Low
1/29/2021	Citigroup	Boost Target	Buy	$249.00 ➝ $257.00	Low
1/14/2021	Mizuho	Boost Target	Buy	$234.00 ➝ $242.00	Low
1/11/2021	Argus	Upgrade	Hold ➝ Buy	$245.00	Medium
1/8/2021	Wolfe Research	Downgrade	Outperform ➝ Peer Perform		High
10/28/2020	Wells Fargo & Company	Boost Target	Overweight	$225.00 ➝ $260.00	Low
10/28/2020	Mizuho	Boost Target	Buy	$215.00 ➝ $234.00	Low
10/27/2020	William Blair	Reiterated Rating	Outperform		Low
10/14/2020	Jefferies Financial Group	Boost Target	Buy	$183.00 ➝ $230.00	Low
7/31/2020	Mizuho	Boost Target	Buy	$186.00 ➝ $215.00	Low
7/29/2020	Bank of America	Boost Target	Buy	$220.00 ➝ $240.00	Medium
7/29/2020	SunTrust Banks	Boost Target	Positive ➝ Buy	$220.00 ➝ $240.00	Medium
7/29/2020	Deutsche Bank Aktiengesellschaft	Boost Target	Buy	$210.00 ➝ $230.00	Medium
7/29/2020	Citigroup	Boost Target	Buy	$214.00 ➝ $249.00	Medium
7/14/2020	Bank of America	Upgrade	Neutral ➝ Buy	$194.00 ➝ $220.00	High
7/13/2020	Wolfe Research	Upgrade	Peer Perform ➝ Outperform	$202.00 ➝ $217.00	High
6/10/2020	Wells Fargo & Company	Reiterated Rating	Buy		Medium
6/8/2020	Robert W. Baird	Boost Target	Outperform	$199.00 ➝ $219.00	Medium
6/4/2020	JPMorgan Chase & Co.	Boost Target	Overweight	$118.00 ➝ $223.00	Medium
6/2/2020	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Buy	$210.00	Medium
5/21/2020	SunTrust Banks	Boost Target	Buy	$200.00 ➝ $220.00	Medium
5/20/2020	Morgan Stanley	Boost Target	Overweight	$241.00 ➝ $244.00	Low
5/15/2020	Mizuho	Upgrade	Neutral ➝ Buy	$158.00 ➝ $186.00	Low
5/5/2020	UBS Group	Boost Target	Buy	$209.00 ➝ $218.00	Low
4/30/2020	JPMorgan Chase & Co.	Boost Target		$149.00 ➝ $188.00	Medium
4/30/2020	Morgan Stanley	Boost Target	Overweight	$172.00 ➝ $241.00	Medium
4/30/2020	Bank of America	Boost Target	Neutral	$147.00 ➝ $190.00	Medium
4/29/2020	KeyCorp	Downgrade	Overweight ➝ Sector Weight		Medium
4/27/2020	Wolfe Research	Upgrade	Underperform ➝ Market Perform	$188.00	Medium
4/27/2020	Citigroup	Upgrade	Neutral ➝ Buy	$204.00 ➝ $214.00	High
4/23/2020	Barclays	Boost Target	Overweight	$188.00 ➝ $195.00	Medium
4/16/2020	Mizuho	Lower Target	Neutral	$163.00 ➝ $158.00	Medium
4/13/2020	SunTrust Banks	Lower Target	Buy	$225.00 ➝ $200.00	Medium
4/8/2020	Morgan Stanley	Lower Target	Overweight	$211.00 ➝ $172.00	High
4/2/2020	JPMorgan Chase & Co.	Lower Target	Overweight	$182.00 ➝ $149.00	Medium
3/30/2020	Wells Fargo & Company	Lower Target	Overweight	$215.00 ➝ $170.00	Medium
3/30/2020	KeyCorp	Lower Target	Overweight	$212.00 ➝ $170.00	High
3/26/2020	Barclays	Lower Target	Overweight	$212.00 ➝ $188.00	Low
3/24/2020	JPMorgan Chase & Co.	Lower Target	Overweight	$204.00 ➝ $182.00	High
2/25/2020	Mizuho	Boost Target	Neutral	$174.00 ➝ $190.00	High
2/18/2020	Morgan Stanley	Boost Target	Overweight	$199.00 ➝ $211.00	Medium
2/14/2020	Evercore ISI	Initiated Coverage	Buy	$215.00	Medium
2/14/2020	Citigroup	Boost Target	Neutral	$179.00 ➝ $204.00	Low
2/13/2020	Piper Sandler	Boost Target		$177.00 ➝ $219.00	Low
1/7/2020	Wells Fargo & Company	Initiated Coverage	Overweight	$210.00	High
1/3/2020	Bank of America	Downgrade	Neutral ➝ Underperform		Low
10/21/2019	UBS Group	Lower Target	Buy	$204.00 ➝ $200.00	Low
8/23/2019	Morgan Stanley	Boost Target	Overweight	$190.00 ➝ $201.00	Medium
8/8/2019	KeyCorp	Boost Target	Overweight	$172.00 ➝ $192.00	Medium
7/26/2019	Morgan Stanley	Boost Target	Overweight	$175.00 ➝ $190.00	High
7/16/2019	Bank of America	Upgrade	Underperform ➝ Neutral	$174.60	Low
7/15/2019	Barclays	Set Target	Buy	$200.00	Low
6/20/2019	Deutsche Bank Aktiengesellschaft	Upgrade	Hold ➝ Buy	$180.00 ➝ $220.00	High
5/20/2019	Mizuho	Boost Target	Neutral	$150.00 ➝ $174.00	Low
5/1/2019	Citigroup	Boost Target	Neutral ➝ Neutral	$157.00 ➝ $176.00	Low
5/1/2019	UBS Group	Boost Target	Buy ➝ Buy	$178.00 ➝ $195.00	Low
4/2/2019	Wolfe Research	Initiated Coverage	Underperform		Low
4/2/2019	Jefferies Financial Group	Upgrade	Hold ➝ Buy	$154.00 ➝ $190.00	Medium
3/18/2019	Barclays	Boost Target	Overweight ➝ Overweight	$165.00 ➝ $173.00	Low
2/27/2019	Credit Suisse Group	Boost Target	Outperform ➝ Outperform	$160.00 ➝ $164.00	Low
2/22/2019	Morgan Stanley	Set Target	Buy	$175.00	Low
2/8/2019	UBS Group	Set Target	Buy	$178.00	Low
1/17/2019	UBS Group	Initiated Coverage	Buy ➝ Buy	$169.00	High
1/3/2019	Bank of America	Downgrade	Neutral ➝ Underperform		Medium
12/20/2018	Morgan Stanley	Set Target	Buy	$177.00	Medium
12/9/2018	The Goldman Sachs Group	Lower Target		$190.00 ➝ $180.00	Low
12/9/2018	Morgan Stanley	Lower Target		$202.00 ➝ $180.00	Low
12/6/2018	KeyCorp	Lower Target	Overweight ➝ Overweight	$210.00 ➝ $165.00	Low
12/3/2018	SunTrust Banks	Lower Target	Buy	$175.00	Low
12/3/2018	Barclays	Lower Target	Overweight ➝ Overweight	$205.00 ➝ $165.00	Medium
12/3/2018	Citigroup	Lower Target	Neutral ➝ Neutral	$171.00 ➝ $160.00	Medium
12/3/2018	William Blair	Reiterated Rating	Buy		Medium
12/3/2018	Morgan Stanley	Lower Target	Overweight ➝ Overweight	$202.00 ➝ $180.00	Medium
12/3/2018	Bank of America	Downgrade	Buy ➝ Neutral		Medium
12/3/2018	Craig Hallum	Downgrade	Buy ➝ Hold		Medium
12/2/2018	The Goldman Sachs Group	Lower Target		$190.00	Medium
11/30/2018	The Goldman Sachs Group	Downgrade	Conviction-Buy ➝ Buy	$190.00 ➝ $180.00	High
10/30/2018	Argus	Downgrade	Buy ➝ Hold		Low
10/25/2018	Robert W. Baird	Lower Target	Outperform	$205.00 ➝ $190.00	Low
10/25/2018	Citigroup	Lower Target	Neutral	$184.00 ➝ $171.00	Low
10/25/2018	Mizuho	Set Target	Hold	$169.00	Low
10/24/2018	William Blair	Reiterated Rating	Outperform		Medium
10/19/2018	Bank of America	Initiated Coverage	Buy ➝ Buy		Low
10/3/2018	Craig Hallum	Lower Target	Buy	$201.00 ➝ $193.00	Low
9/19/2018	Mizuho	Reiterated Rating	Neutral		Low
9/10/2018	Morgan Stanley	Boost Target	Overweight ➝ Buy	$192.00 ➝ $202.00	Low
9/4/2018	Credit Suisse Group	Lower Target	Outperform ➝ Outperform	$197.00 ➝ $195.00	Medium
8/22/2018	Argus	Reiterated Rating	Buy		Low
8/20/2018	Deutsche Bank Aktiengesellschaft	Lower Target	Hold ➝ Hold	$195.00 ➝ $190.00	Medium
7/26/2018	Mizuho	Reiterated Rating	Hold	$189.00	Low
7/26/2018	Jefferies Financial Group	Reiterated Rating	Hold ➝ Neutral	$180.00	Low
7/20/2018	SunTrust Banks	Reiterated Rating	Buy	$220.00	Low
6/27/2018	Deutsche Bank Aktiengesellschaft	Downgrade	Buy ➝ Hold	$172.00	Medium
6/7/2018	KeyCorp	Upgrade	Sector Weight ➝ Overweight	$210.00	Low

(Data available from 6/2/2018 forward)

News Sentiment Rating

0.58 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

4 very positive mentions
9 positive mentions
6 negative mentions
0 very negative mentions

Mentions as of

11/4/2022

2 very positive mentions
3 positive mentions
0 negative mentions
0 very negative mentions

Mentions as of

12/4/2022

1 very positive mentions
6 positive mentions
1 negative mentions
0 very negative mentions

Mentions as of

1/3/2023

8 very positive mentions
12 positive mentions
0 negative mentions
1 very negative mentions

Mentions as of

2/2/2023

13 very positive mentions
19 positive mentions
3 negative mentions
1 very negative mentions

Mentions as of

3/4/2023

10 very positive mentions
7 positive mentions
1 negative mentions
0 very negative mentions

Mentions as of

4/3/2023

17 very positive mentions
23 positive mentions
8 negative mentions
1 very negative mentions

Mentions as of

5/3/2023

15 very positive mentions
19 positive mentions
4 negative mentions
1 very negative mentions

Mentions as of

6/2/2023

Current Sentiment

Recent Stories by Sentiment

Laboratory Corp. of America Holdings operates as a life sciences company, which engages in the provision of vital information to help health professionals make clear and confident decisions. It operates through the Drug Development and Diagnostics segments. The Drug Development segment consists of lead optimization, preclinical safety assessment, analytical services, clinical trials, central laboratories, biomarkers, and companion diagnostics, market access, and technology solutions. The Diagnostics segment includes primary care, women's health, specialty medicine, oncology, ACOs, and hospitals and health systems. The company was founded in 1971 and is headquartered in Burlington, NC.

Today's Range

Now: $216.98

$213.77

$218.43

50 Day Range

MA: $223.95

$211.93

$234.01

52 Week Range

Now: $216.98

$200.32

$263.13

Volume

647,880 shs

Average Volume

607,508 shs

Market Capitalization

$19.22 billion

P/E Ratio

19.69

Dividend Yield

1.36%

Beta

1.04

Frequently Asked Questions

What sell-side analysts currently cover shares of Laboratory Co. of America?: The following sell-side analysts have issued stock ratings on Laboratory Co. of America in the last year: Argus, Citigroup Inc., Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Mizuho, Morgan Stanley, Robert W. Baird, StockNews.com, Truist Financial Co., Wells Fargo & Company, and William Blair.
View the latest analyst ratings for LH.
What is the current price target for Laboratory Co. of America?: 8 Wall Street analysts have set twelve-month price targets for Laboratory Co. of America in the last year. Their average twelve-month price target is $273.50, suggesting a possible upside of 28.7%. Morgan Stanley has the highest price target set, predicting LH will reach $303.00 in the next twelve months. Citigroup Inc. has the lowest price target set, forecasting a price of $235.00 for Laboratory Co. of America in the next year.
View the latest price targets for LH.
What is the current consensus analyst rating for Laboratory Co. of America?: Laboratory Co. of America currently has 2 hold ratings and 7 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe LH will outperform the market and that investors should add to their positions of Laboratory Co. of America.
View the latest ratings for LH.
What other companies compete with Laboratory Co. of America?: Other companies that are similar to Laboratory Co. of America include Quest Diagnostics, Exact Sciences, Natera, Insulet and Cooper Companies. Learn More about companies similar to Laboratory Co. of America.
How do I contact Laboratory Co. of America's investor relations team?: Laboratory Co. of America's physical mailing address is 358 South Main Street, BURLINGTON NC, 27215. The medical research company's listed phone number is (336) 229-1127 and its investor relations email address is [email protected]. The official website for Laboratory Co. of America is www.labcorp.com. Learn More about contacing Laboratory Co. of America investor relations.

Laboratory Co. of America - LH Stock Price Target and Predictions

Analyst Price Target for LH

Current Consensus is Buy

Past Monthly Recommendations

Latest Recommendations

News Sentiment Rating

0.58 (Buy)

News Sentiment Over Time

Current Sentiment

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of Laboratory Co. of America?

What is the current price target for Laboratory Co. of America?

What is the current consensus analyst rating for Laboratory Co. of America?

What other companies compete with Laboratory Co. of America?

How do I contact Laboratory Co. of America's investor relations team?